on EUROBIO-SCIENTIFIC (EPA:ALERS)
EB Development Surpasses 90% Stake in Eurobio Scientific
Paris, May 19, 2024 – Eurobio Scientific, a prominent French company in in vitro medical diagnostics and life sciences, announced that EB Development has acquired over 90% of its share capital. This significant milestone follows EB Development's purchase of Eurobio Scientific shares in the market, raising its ownership to an exact 90.01% shareholding and equivalent voting rights.
Eurobio Scientific is known for its contributions to specialty in vitro diagnostics, covering areas such as transplantation, immunology, and infectious diseases. The company boasts a strong international presence with production units and subsidiaries across Europe and the USA.
The next major financial event for Eurobio Scientific is its Annual General Meeting, scheduled for June 19, 2025.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all EUROBIO-SCIENTIFIC news